Page 30 - Use Listing News Today

Covid-19: India fast-tracks rollout of vaccines approved by international regulators Web report/Mumbai AFP Companies will still have to ensure safety outcome assessments of drug ahead of rollout International pharma firms who have approvals for their Covid-19 vaccines from regulators in specific countries will now be able to sell them in India almost immediately as they will not have to conduct post-launch bridging trials and get the quality and stability tested again in the country. The Drug C...

GENEVA, June 1 (Xinhua) -- The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. "I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective, and quality assured following two doses of the inactivated vaccine," WHO Director-General Tedros Adhanom Ghebreyesus said at a WHO press briefing on Tuesday. "Furth...

Globally available Covid 19 vaccines can now be launched in India without the requirement of post approval clinical trials and testing every batch of the vaccine.

Pfizer, which is ready to offer an undisclosed number doses to India between July and October, had in talks with the government stressed on indemnity.

DCGI said the requirement of conducting post approval bridging clinical trials and requirement of testing of every batch of vaccine by the CDL can be exempted, if the vaccine lot/batch is certified and released by National Control Laboratory of country of

Testing each batch of vaccines no more required after Pfizer, Cipla make similar demands

COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trials - Cipla, which has been looking to commit USD 1 billion into bringing Moderna's single-dose mRNA booster vaccine to India, also requested an exemption.

Baku, June 2, AZERTAC The World Health Organization on Tuesday approved the vaccine made by the Chinese drugmaker Sinovac for emergency use against COVID-19, according to Anadolu Agency. It is the eighth coronavirus vaccine authorized by the global health organization. The WHO said it is “giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy, and manufacturing.” The CoronaVac vaccine is produced by the Beijing-...

Roundup: China committed to helping world eliminate vaccine divide Xinhua 02 Jun 2021, 19:30 GMT+10 GENEVA, June 2 (Xinhua) -- The World Health Organization (WHO) on Tuesday validated Chinas CoronaVac vaccine for emergency use, the second Chinese vaccine approved by the WHO. The validation means Chinas vaccines will play a greater role in helping the world eliminate the vaccine divide that is impeding global efforts to curb the COVID-19 pandemic. Unlike some developed countries which are hoar...

  The vaccine is produced by the Beijing-based pharmaceutical company Sinovac. "The world desperately needs multiple COVID-19 vaccines to address the huge access inequity across the globe," said Dr Maringela Simao, WHO Assistant-Director General for Access to Health Products. "We urge manufacturers to participate in the COVAX Facility, share their know-how and data and contribute to bringing the pandemic under control," Dr. Simao said. On May 7, WHO granted conditional approval to Chinas Sin...